[Class : 5] Biological Tissue Cultures For Veterinary Purposes; Biological Tissue Cultures For Medical Purposes; Biological Preparations For Veterinary Purposes: Biological Preparations For Medical Purposes; Enzyme Preparations For Veterinary Purposes; Enzyme Preparations For Medical Purposes; Enzyme Dietary Supplements.
Renewal of trademark is due. Renewal request in prescribed form is to be filed by the applicant.
View +8 more Brands for Magellan Life Sciences Private Limited.
Documents
Form DPT-3-21052020-signed
Form MGT-7-07122019_signed
Form AOC-4-07122019_signed
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-25112019
Optional Attachment-(2)-25112019
Optional Attachment-(1)-25112019
List of share holders, debenture holders;-25112019
Directors report as per section 134(3)-25112019
Details of salient features and justifications for entering into Contracts/Arrangements/Transactions with related parties as per section 188 (1) - Form AOC - 2-25112019
Form DPT-3-02072019
Form MGT-7-27022019_signed
Form AOC-4-27022019_signed
Optional Attachment-(1)-20022019
List of share holders, debenture holders;-20022019
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-20022019
Directors report as per section 134(3)-20022019
Optional Attachment-(1)-19022019
Form DIR-12-19022019_signed
Directors report as per section 134(3)-16042018
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-16042018
Form AOC-4-16042018_signed
Optional Attachment-(1)-11042018
List of share holders, debenture holders;-11042018
Form MGT-7-11042018_signed
Optional Attachment-(1)-12032018
Optional Attachment-(2)-12032018
Form DIR-12-12032018_signed
Declaration of the appointee director, Managing director, in Form No. DIR-2;-12032018
Form AOC-4-30112016_signed
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-29112016